Malden, MA, United States of America

Hone Guo

This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 377(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Hone Guo

Introduction

Hone Guo is an accomplished inventor based in Malden, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug delivery systems. His innovative work focuses on the sustained release of synergistic drugs, which has the potential to improve treatment outcomes for various medical conditions.

Latest Patents

Hone Guo holds a patent titled "Means to achieve sustained release of synergistic drugs by conjugation." This patent describes a codrug composition that consists of at least two drug compounds covalently linked via a labile bond or ionically linked to form a single working composition. The methods of use for this codrug are aimed at treating various medical conditions. The codrug can be administered alone or in the form of a bioerodible or nonbioerodible substance. He has 1 patent to his name.

Career Highlights

Hone Guo is affiliated with the University of Kentucky Research Foundation, where he continues to advance his research in drug development. His work is characterized by a commitment to improving therapeutic strategies through innovative drug formulations.

Collaborations

Hone Guo has collaborated with notable colleagues such as Paul Ashton and Peter Anthony Crooks. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hone Guo's contributions to the field of pharmaceuticals through his innovative patent demonstrate his dedication to improving medical treatments. His work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…